Literature DB >> 11230367

Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide.

M S Goligorsky1, J Chen, S Brodsky.   

Abstract

Clinical manifestations of diabetic nephropathy are an expression of diabetic microangiopathy. This review revisits the previously proposed Steno hypothesis and advances our hypothesis that development of endothelial cell dysfunction represents a common pathophysiological pathway of diabetic complications. Specifically, the ability of glucose to scavenge nitric oxide is proposed as the initiation phase of endothelial dysfunction. Gradual accumulation of advanced glycated end products and induction of plasminogen activator inhibitor-1, resulting in the decreased expression of endothelial nitric oxide synthase and reduced generation of nitric oxide, are proposed to be pathophysiologically critical for the maintenance phase of endothelial dysfunction. The proposed conceptual shift toward the role of endothelial dysfunction in diabetic complications may provide new strategies for their prevention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230367     DOI: 10.1161/01.hyp.37.2.744

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 2.  Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitus.

Authors:  Mariella Trovati; Giovanni Anfossi
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

Review 3.  Vascular endothelium in diabetes.

Authors:  Michael S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2016-11-16

Review 4.  Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2013-11-06

5.  Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy.

Authors:  Paolo Tessari; Diego Cecchet; Alessandra Cosma; Monica Vettore; Anna Coracina; Renato Millioni; Elisabetta Iori; Lucia Puricelli; Angelo Avogaro; Monica Vedovato
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

6.  Gene expression programs of mouse endothelial cells in kidney development and disease.

Authors:  Eric W Brunskill; S Steven Potter
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 7.  Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.

Authors:  Inge A M van den Oever; Hennie G Raterman; Mike T Nurmohamed; Suat Simsek
Journal:  Mediators Inflamm       Date:  2010-06-15       Impact factor: 4.711

8.  Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension.

Authors:  F Palm; J Cederberg; P Hansell; P Liss; P-O Carlsson
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

9.  Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway.

Authors:  Enrica Favaro; Ilaria Miceli; Benedetta Bussolati; Michel Schmitt-Ney; Michel Schimitt-Ney; Paolo Cavallo Perin; Giovanni Camussi; Maria M Zanone
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

10.  Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy.

Authors:  Yukio Yuzawa; Ichiro Niki; Tomoki Kosugi; Shoichi Maruyama; Futoshi Yoshida; Motohiro Takeda; Yoshiaki Tagawa; Yukiko Kaneko; Toshihide Kimura; Noritoshi Kato; Jyunichiro Yamamoto; Waichi Sato; Takahiko Nakagawa; Seiichi Matsuo
Journal:  J Am Soc Nephrol       Date:  2008-06-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.